End-of-day quote
Other stock markets
|
||
- USD | - |
|
Chart calendar Mylan Inc
Upcoming events on Mylan Inc
Past events on Mylan Inc
2024-06-11 09:20 am | Goldman Sachs Global Healthcare Conference |
2024-06-06 08:00 am | Jefferies Global Healthcare Conference |
2024-05-22 | Détachement de |
2024-05-14 01:00 pm | BofA Securities Health Care Conference |
2024-05-09 08:30 am | Q1 2024 Earnings Call |
2024-05-09 06:59 am | Q1 2024 Earnings Release |
2024-03-27 10:00 am | R&D Day |
2024-03-07 | Détachement de |
2024-02-28 08:30 am | Q4 2023 Earnings Call |
2024-02-28 06:30 am | Q4 2023 Earnings Release |
2024-01-10 01:30 pm | JPMorgan Healthcare Conference |
2023-12-15 11:00 am | Annual General Meeting |
2023-11-21 | Détachement de |
2023-11-15 04:30 am | Jefferies London Healthcare Conference |
2023-11-07 05:00 pm | Q3 2023 Earnings Call |
2023-11-07 04:02 pm | Q3 2023 Earnings Release |
2023-08-22 | Détachement de |
2023-08-07 08:30 am | Q2 2023 Earnings Call |
2023-08-07 06:59 am | Q2 2023 Earnings Release |
2023-06-13 04:20 pm | Goldman Sachs Global Healthcare Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 11 501 11 537 -0.32% | 11 946 12 273 -2.66% | 17 886 17 881 0.03% | 16 263 16 372 -0.67% | 15 427 15 465 -0.25% | 14 923 |
EBITDA Million USD | Released Forecast Spread | 3 540 3 500 1.12% | 3 654 4 483 -18.49% | 6 426 6 464 -0.59% | 5 777 5 852 -1.29% | 5 124 5 197 -1.4% | 4 797 |
EBIT Million USD | Released Forecast Spread | 3 264 3 212 1.62% | 3 376 3 864 -12.61% | 6 046 6 111 -1.07% | 5 475 5 566 -1.62% | 4 725 4 851 -2.6% | 4 473 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 154 807 -80.87% | -721 3 677 -119.61% | -664 -580 -14.55% | 2 813 878 220.41% | 203 1 198 -83.06% | 3 933 |
Net income Million USD | Released Forecast Spread | 16,8 427 -96.07% | -670 1 449 -146.24% | -1 269 -952 -33.29% | 2 079 1 328 56.46% | 54,7 812 -93.26% | 1 812 |
EPS USD | Released Forecast Spread | 0,03 0,81 -96.3% | -1,11 1,62 -168.59% | -1,05 -0,77 -36.36% | 1,71 1,01 69.62% | 0,05 0,84 -94.02% | 1,31 |
Announcement Date | 27/02/20 | 01/03/21 | 28/02/22 | 27/02/23 | 28/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 4 192 4 258 -1.55% | 4 117 4 185 -1.62% | 4 078 4 136 -1.39% | 3 876 3 988 -2.8% | 3 729 3 812 -2.18% | 3 919 3 862 1.45% | 3 942 3 997 -1.37% | 3 837 3 877 -1.03% | 3 663 3 691 -0.75% | 3 718 | 3 744 | 3 784 | 3 739 | 3 849 |
EBITDA Million USD | Released Forecast Spread | 1 586 1 445 9.8% | 1 482 1 443 2.73% | 1 498 1 431 4.69% | 1 211 1 288 -6% | 1 341 1 222 9.69% | 1 306 1 255 4.04% | 1 360 1 293 5.2% | 1 117 1 220 -8.44% | 1 193 1 207 -1.13% | 1 170 | 1 230 | 1 219 | ||
EBIT Million USD | Released Forecast Spread | 1 551 1 375 12.82% | 1 425 1 375 3.57% | 1 415 1 368 3.4% | 1 085 1 166 -6.96% | 1 255 1 151 9.02% | 1 226 1 178 4.12% | 1 257 1 208 4.05% | 987 1 100 -10.29% | 1 100 1 104 -0.38% | 1 117 | 1 148 | 1 114 | 1 111 | 1 101 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 528 48,0 998.96% | 402 260 54.69% | -855 140 -710.71% | 3 164 | 310 | 255 | ||||||||
Net income Million USD | Released Forecast Spread | 399 149 167.56% | 314 234 34.21% | 354 357 -0.78% | 1 011 257 292.86% | 225 154 46.31% | 264 225 17.13% | 332 246 35.03% | -766 114 -771.58% | 114 123 -7.07% | 1 269 | 200 | 229 | ||
EPS USD | Released Forecast Spread | 0,33 0,08 304.11% | 0,26 0,19 36.43% | 0,29 0,42 -31.07% | 0,83 0,15 453% | 0,19 0,23 -15.82% | 0,22 0,20 8.2% | 0,27 0,34 -20.08% | -0,64 0,26 -344.8% | 0,09 0,12 -22.89% | 0,14 | 0,18 | 0,32 | ||
Announcement Date | 09/05/22 | 08/08/22 | 07/11/22 | 27/02/23 | 08/05/23 | 07/08/23 | 07/11/23 | 28/02/24 | 09/05/24 | - | - | - | - | - |
2024-07-15 | CAMURUS AB: Q2 2024 Earnings Release |
2024-07-16 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-17 06:45 am | JOHNSON & JOHNSON: Q2 2024 Earnings Release |
2024-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-18 01:00 am | NOVARTIS AG: Q2 2024 Earnings Release |
2024-07-18 | TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release |
2024-07-21 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-21 | ALMIRALL, S.A.: Q2 2024 Earnings Release |
2024-07-22 | TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | INNOVIVA, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Mylan Inc
2024-07-10 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2024-07-09 | LOTUS PHARMACEUTICAL CO., LTD.: June 2024 Sales and Revenue Release |
2024-07-09 07:35 am | SCINOPHARM TAIWAN, LTD.: June 2024 Sales and Revenue Release |
2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
2024-07-02 05:05 am | ONENESS BIOTECH CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
- Stock Market
- Equities
- VTRS Stock
- Stock
- Calendar Mylan Inc